This work was in part supported by grant RO1-AG15347 from the National Institute on Aging (to H.M.) and by grant RO1-MH56528 from the National Institute of Mental Health (to G.P.).

  • 1
    Baskaya M.F., Hu M.D.Y., Donaldson D., Maley M., Rao A.M., Prasad M.R., Dempsey R.J. (1996) Protective effect of the 5-lipoxygenase inhibitor AA-861 on cerebral edema after transient ischemia.J. Neurosurg.85,112116.
  • 2
    Breitner J.C.S. (1996) Inflammatory processes and antiinflammatory drugs in Alzheimer's disease : a current appraisal.Neurobiol. Aging 17,789794.
  • 3
    Christie M.J., Vaughan C.W., Ingram S.L. (1999) Opioids, NSAIDs and 5-lipoxygenase inhibitors act synergistically in brain via arachidonic acid metabolism.Inflamm. Res.48,14.
  • 4
    Dixon R.A.F., Diehl R.E., Opas E., Rands E., Vickers P.J., Evans J.F., Gillard J.W., Miller D.K. (1990) Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis.Nature 343,282284.
  • 5
    Funder J.W. (1997) Glucocorticoid and mineralocorticoid receptors : biology and clinical relevance.Annu. Rev. Med.48,231240.
  • 6
    Hoshiko S., Radmar O., Samuelsson B. (1990) Characterization of the human 5-lipoxygenase gene promoter.Proc. Natl. Acad. Sci. USA 87,90739077.
  • 7
    Lammers C., Schweitzer P., Facchinetti P., Arrang J., Madamba S.G., Siggins G.R., Piomelli D. (1996) Arachidonate 5-lipoxygenase and its activating protein : prominent hippocampal expression and role in somatostatin signaling.J. Neurochem.66,147152.
  • 8
    Landfield P.W., Waymire J.C., Lynch G. (1978) Hippocampal aging and adrenocorticoids : quantitative correlations.Science 202,10981102.
  • 9
    Lepley R.A., Muskardin D.T., Fitzpatrick F.L. (1996) Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase.J. Biol. Chem.271,61796184.
  • 10
    Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. (1951) Protein measurement with the Folin phenol reagent.J. Biol. Chem.193,265275.
  • 11
    Luisi B.F., Xu W.X., Otwinowski Z., Freedman L.P., Yamamoto K.R., Sigler P.B. (1991) Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA.Nature 352,497505.
  • 12
    Lupien S.J., DeLeon M., DeSanti S., Convit A., Tarshish C., Nair N.P.V., Thakur M., McEwen B.S., Hauger R.L., Meaney M.J. (1998) Cortisol levels during human aging predict hippocampal atrophy and memory deficits.Nat. Neurosci.1,69-73.
  • 13
    Maccarrone M., Navarra M., Corasanti M.T., Nistico G., Finazzi Agro A. (1998) Cytotoxic effect of HIV-1 coat glycoprotein gp120 on human neuroblastoma CHP100 cells involves activation of arachidonate cascade.Biochem. J.333,4549.
  • 14
    Magri F., Locatelli M., Balza G., Molla G., Cuzzoni G., Fioravanti M., Solerte S.B., Ferrari E. (1997) Changes in endocrine circadian rhythms as markers of physiological and pathological brain aging.Chronobiol. Int.14,385396.
  • 15
    Manev H. (1999) 5-Lipoxygenase gene promoter polymorphism and onset of Alzheimer's disease.Med. Hypotheses (in press).
  • 16
    Manev H., Uz T., Kharlamov A., Joo J. -Y. (1996) Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats.FASEB J.10,15461551.
  • 17
    Manev H., Uz T., Qu T. (1998) Early upregulation of hippocampal 5-lipoxygenase following systemic administration of kainate to rats.Restor. Neurol. Neurosci.12,8185.
  • 18
    Ohtsuki T., Matsumoto M., Hayashi Y., Yamamoto K., Kitagawa K., Ogawa S., Yamamoto S., Kamada T. (1995) Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in the ischemic brain.Am. J. Physiol.268,H1249H1257.
  • 19
    Oxenkrug G.F., McIntyre I.M., Gershon S. (1984) Effects of pinealectomy and aging on the serum corticosterone circadian rhythm in rats.J. Pineal Res.1,181185.
  • 20
    Peters-Golden M. (1998) Cell biology of the 5-lipoxygenase pathway.Am. J. Respir. Crit. Care Med.157 (Suppl.) , S227S232.
  • 21
    Piomelli D. (1994) Eicosanoids in synaptic transmission.Crit. Rev. Neurobiol.8,6583.
  • 22
    Riddick C.A., Ring W.L., Baker J.R., Hodulik C.R., Bigby T.D. (1997) Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells.Eur. J. Biochem.246,112118.
  • 23
    Sapolsky R.M. & Pulsinelli W. (1985) Glucocorticoids potentiate ischemic injury to neurons : therapeutic implications.Science 229,13971400.
  • 24
    Simmet T. & Tippler B. (1991) On the relation between cerebral cysteinyl-leukotriene formation and epileptic seizures.Brain Res.540,283286.
  • 25
    Steinhilber D., Brungs M., Werz O., Wiesenberg I., Danielsson C., Kahlen J., Nayeri S., Schräder M., Carlberg C. (1995) The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes.J. Biol. Chem.270,70377040.
  • 26
    Uz T., Longone P., Manev H. (1997) Increased hippocampal 5-lipoxygenase mRNA content in melatonin-deficient, pinealectomized rats.J. Neurochem.69,22202223.
  • 27
    Uz T., Pesold C., Longone P., Manev H. (1998) Aging-associated up-regulation of neuronal 5-lipoxygenase expression : putative role in neuronal vulnerability.FASEB J.12,439449.
  • 28
    Wiegers G.J. & Reul J.M.H.M. (1998) Induction of cytokine receptors by glucocorticoids : functional and pathological significance.Trends Pharmacol. Sci.19,317321.
  • 29
    Wiesenberg I., Missbach M., Carlberg C. (1998) The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling.Restor. Neurol. Neurosci.12,143150.